Verrica Pharmaceuticals Inc. Common Stock (VRCA)
Verrica Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing dermatology solutions. The company's lead products target FDA-approved indications for the treatment of skin conditions caused by viruses, such as molluscum contagiosum and common warts. Verrica aims to address unmet medical needs with innovative and well-tolerated therapies for dermatological issues.
Company News
Verrica Pharmaceuticals reported strong Q2 2025 financial results, with non-GAAP EPS of $0.25 and GAAP revenue of $12.7 million, significantly exceeding analyst expectations. The company saw improved performance driven by YCANTH product sales and a major milestone payment from Torii Pharmaceutical.
Verrica Pharmaceuticals announced the acceptance of two abstracts featuring positive preliminary results from a Phase 2 study of its investigational therapy VP-315 for the treatment of basal cell carcinoma. The data showed promising safety, tolerability, and antitumor efficacy.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Roth MKM cut the price target for Roblox Corporation (NYSE:RBLX) from $55 to $35. Roth MKM analyst Eric Handler downgraded the stock from Buy to Neutral. Roblox shares fell 1.6% to close at $30.96 on Monday. See how other analysts view this stock. Needham boosted the price target for Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) from $8 to $16. Needham analyst Serge Belanger maintained a Buy rating. Verrica Pharmaceuticals shares jumped 19.5% to close at $9.56 on Monday. See how other analysts view this stock. Baird cut Fortrea Holdings Inc. (NASDAQ:FTRE) price target from $45 to $36. Baird analyst Eric Coldwell upgraded the stock from Neutral to Outperform. Fortrea ...Full story available on Benzinga.com
Verrica Pharmaceuticals (VRCA) delivered earnings and revenue surprises of 29.63% and 41.97%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Check these penny stocks out for your watchlist The post Hot Penny Stocks to Buy Now? 3 to Watch in Early July appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.